QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
ImmunityBio, Inc.
Tesaro, Inc.
Trishula Therapeutics, Inc.
The Netherlands Cancer Institute
OncoC4, Inc.
IGM Biosciences, Inc.
Karyopharm Therapeutics Inc
Eli Lilly and Company
Biosplice Therapeutics, Inc.
Cantargia AB
AstraZeneca
Eli Lilly and Company
The Netherlands Cancer Institute
Memorial Sloan Kettering Cancer Center
Emory University